ANAB
AnaptysBio Inc
NASDAQ: ANAB · HEALTHCARE · BIOTECHNOLOGY
$65.73
+5.44% today
Updated 2026-04-30
Market cap
$1.81B
P/E ratio
—
P/S ratio
7.73x
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$11 – $72
Volume
0.6M
AnaptysBio Inc (ANAB) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.91M | $25.07M | $56.28M | $62.18M | $329.36M | $509.00M | $435.20M | $416.55M | $643.07M | $610.38M | $452.39M | $483.83M |
| Cash & equivalents | $2.81M | $22.19M | $51.68M | $51.23M | $81.19M | $113.60M | $171.02M | $250.46M | $495.73M | $71.31M | $35.97M | $123.08M |
| Current assets | $3.05M | $24.40M | $53.46M | $58.21M | $252.70M | $434.22M | $377.73M | $396.56M | $553.88M | $447.20M | $406.83M | $431.88M |
| Total liabilities | $3.77M | $19.07M | $13.94M | $22.91M | $21.78M | $22.63M | $30.19M | $19.82M | $286.64M | $348.28M | $364.29M | $412.97M |
| Current liabilities | $3.16M | $11.68M | $7.38M | $5.71M | $14.09M | $21.84M | $29.54M | $19.82M | $16.10M | $26.05M | $37.44M | $45.43M |
| Long-term debt | — | $4.79M | $4.90M | $13.81M | $7.55M | $625000.00 | — | — | — | — | — | — |
| Shareholder equity | $145000.00 | $5.99M | $42.34M | $39.27M | $307.58M | $486.37M | $405.01M | $396.73M | $356.43M | $262.10M | $88.10M | $70.87M |
| Retained earnings | $-48.79M | $-45.26M | $-50.66M | $-54.92M | $-85.03M | $-146.69M | $-244.03M | $-263.96M | $-321.75M | $-450.48M | $-614.10M | $-759.33M |
| Accounts receivable | — | $1.46M | $1.23M | $5.34M | $1.60M | $174000.00 | — | $0.00 | $876000.00 | $1.42M | $6.85M | $40.77M |
| Inventory | — | — | — | $1.00 | $0.00 | — | — | — | $1.00 | $1.00 | $1.00 | — |
| Goodwill | — | — | — | — | $0.00 | — | — | — | — | — | — | — |